Literature DB >> 21509410

Schizophrenia among Sesotho speakers in South Africa.

L Mosotho1, D Louw, F J Calitz.   

Abstract

OBJECTIVE: The aim of this study is to investigate the clinical presentation of schizophrenia among Sesotho speakers.
METHOD: A sample of 100 participants diagnosed with schizophrenia was evaluated using the Psychiatric Interview Questionnaire.
RESULTS: Core symptoms of schizophrenia among Sesotho speakers do not differ significantly from other cultures. However, the content of psychological symptoms such as delusions and hallucinations is strongly affected by cultural variables. Somatic symptoms such as headaches, palpitations, dizziness and excessive sweating were prevalent among the Sesotho-speaking participants suffering from schizophrenia.
CONCLUSION: In South Africa, as is the case throughout the African continent, health professionals are still trained in Western models, especially DSM-IV-TR and ICD-10. Certain changes should be made to these models to account for cultural differences that were found in this research.

Entities:  

Mesh:

Year:  2011        PMID: 21509410     DOI: 10.4314/ajpsy.v14i1.65473

Source DB:  PubMed          Journal:  Afr J Psychiatry (Johannesbg)


  3 in total

1.  Demographic, clinical and social characteristics of forensic patients diagnosed with schizophrenia at the Free State Psychiatric Complex, Bloemfontein, South Africa.

Authors:  Nkomile Ntswaki Clourinah Setlaba; Nathaniel Lehlohonolo Mosotho; Gina Joubert
Journal:  Psychiatr Psychol Law       Date:  2020-03-13

2.  The content of delusions in a sample of South African Xhosa people with schizophrenia.

Authors:  Megan M Campbell; Goodman Sibeko; Sumaya Mall; Adam Baldinger; Mohamed Nagdee; Ezra Susser; Dan J Stein
Journal:  BMC Psychiatry       Date:  2017-01-24       Impact factor: 3.630

3.  Perceptions of psychosocial disability amongst psychiatric service users and caregivers in South Africa.

Authors:  Carrie Brooke-Sumner; Crick Lund; Inge Petersen
Journal:  Afr J Disabil       Date:  2014-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.